Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
The electronic medicines compendium (emc) no longer publishes a Summary of Product Characteristics for this product, which usually means it is no longer marketed in the UK. The patient leaflet below is kept for reference, but the product may not be available.
If you were prescribed this medicine, other products containing Alclometasone dipropionate may still be available. Do not stop your treatment — ask your pharmacist or GP what to use instead.
for This medicine contains an active ingredient called alclometasone dipropionate which belongs to a group of medicines called topical corticosteroids. These medicines are used on the surface of the skin to reduce the redness and itchiness caused by certain skin problems. In adults and children, this medicine is used to reduce redness and itchiness caused by certain skin problems (for example eczema and dermatitis):
e alclometasone Do not use this medicine:
Pregnancy and breast-feeding If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine. This medicine contains propylene glycol This medicine contains 250mg propylene glycol per gram of cream. Propylene glycol may cause skin irritation.
alclometasone Always use this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure. For adults and children, apply a thin layer of this medicine to the affected area two or three times a day, unless otherwise instructed by your doctor. Ask your doctor about the duration of the treatment. You must not use a large amount of this medicine in the same area for a long time (for example every day for many weeks and months). Do not apply this medicine under dressings, such as a plaster or bandage, as this makes it easier for the active ingredient to pass through the skin and possibly cause some unwanted effects. If the cream is for your child, do not use it under a nappy, as this makes it easier for the active ingredient to pass through the skin and possibly cause some unwanted effects. Instructions for use: 1. Wash your hands 2. Apply a thin film of the cream and rub gently until it has all disappeared 3. Wash your hands, unless the cream is used to treat your hands. If you use more of this medicine than you should Tell your doctor if:
Like all medicines, this medicine can cause side effects, although not everybody gets them. Most people find that when the cream is used correctly, it does not cause any problems. However, if you use more cream than you should, particularly on your face, it can cause:
05800170X01450029L02-M040U6007
Warnings and precautions Talk to your doctor or pharmacist before using this medicine:
alclometasone Keep this medicine out of the sight and reach of children. Do not use this medicine after the expiry date which is stated on the pack. The expiry date refers to the last day of that month. Do not store above 25°C. Do not throw away any medicines via wastewater. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
What this medicine contains The active substance is alclometasone dipropionate 0.05% w/w. The other ingredients are: propylene glycol, white soft paraffin, cetostearyl alcohol, glyceryl stearate PEG 100 stearate, polyoxyethylene (20) cetyl ether, sodium dihydrogen phosphate dihydrate, 4-chloro-M-cresol, phosphoric acid, purified water. What this medicine looks like and contents of the pack This medicine is a smooth, white to off white cream contained in a 50g aluminium tube with a screw cap. Marketing Authorisation Holder and Manufacturer Marketing Authorisation Holder: Aspire Pharma Ltd. Unit 4, Rotherbrook Court Bedford Road Petersfield Hampshire GU32 3QG United Kingdom. Manufacturer: TIOFARMA B.V. Benjamin Franklinstraat 5-10 3261 LW Oud-Beijerland The Netherlands. This leaflet was last revised in July 2024
1010326-P7.1
Alclometasone Dipropionate 0.05% w/w Cream comes as cream. Always follow the dose your doctor or pharmacist has given you, and read the leaflet that comes with the medicine.
The active substance in Alclometasone Dipropionate 0.05% w/w Cream is alclometasone dipropionate.
This leaflet reproduces the patient information leaflet approved for Alclometasone Dipropionate 0.05% w/w Cream, as published on the electronic medicines compendium (emc). The version printed inside your medicine’s packaging is the one that applies to you.
Whether a medicine is available over the counter or on prescription only depends on its licence. Check the leaflet, or ask your pharmacist — they can tell you straight away.
The text above reproduces the patient information leaflet approved for this medicine, restructured for easier reading.
Alclometasone dipropionate is a non-fluorinated topically active synthetic corticosteroid indicated for the treatment of inflammatory and pruritic manifestations of corticosteroid responsive dermatoses.
For topical administration
For adults and children, apply a thin film of alclometasone cream to the affected area two or three times daily or as directed by the doctor.
Massage gently into the skin until the medication disappears.
Hypersensitivity to any of the ingredients; rosacea; acne and perioral dermatitis, tuberculous and viral lesions or the skin, particularly Herpes Simplex; vaccinia: varicella.
Alclometasone cream should not be used in fungal or bacterial skin infections.
The label will state moderate steroid.
As with all topical steroids, long term continuous therapy should be avoided where possible, particularly in infants and children as adrenal suppression may occur even without occlusion. In infants the napkin may act as an occlusive dressing and thus increase absorption.
For dermatologic use only.
If irritation or sensitization develops with the use of alclometasone, treatment should be discontinued and appropriate therapy instituted.
Any of the side effects that have been reported following systemic use of corticosteroids, including adrenal suppression, may also occur with topical corticosteroids, especially in infants and children.
Systemic absorption of topical corticosteroids may be increased if extensive body surface areas are treated or if the occlusive technique is used. Suitable precautions should be taken under these conditions or when long-term use is anticipated, particularly in infants and children.
Paediatric Use:
Paediatric patients may demonstrate greater susceptibility to topical corticosteroid-induced hypothalamic-pituitary-adrenal (HPA) axis suppression and to exogenous corticosteroid effects than mature patients because of greater absorption due to a larger skin surface area to body weight ratio.
HPA axis suppression, Cushing's syndrome, linear growth retardation, delayed weight gain, and intracranial hypertension have been reported in children receiving topical corticosteroids. Manifestations of adrenal suppression in children include low plasma cortisol levels, and an absence of response to ACTH stimulation. Manifestations of intracranial hypertension include a bulging fontanelle, headaches, and bilateral papilledema.
Alclometasone cream products are not for ophthalmic use.
Instruct patients not to smoke or go near naked flames - risk of severe burns. Fabric (clothing, bedding, dressings etc.) that has been in contact with this product burns more easily and is a serious fire hazard. Washing clothing and bedding may reduce product build-up but not totally remove it.
Topical steroid withdrawal syndrome
Long term use of topical steroids can result in the development of rebound flares after stopping treatment (topical steroid withdrawal syndrome). A severe form of rebound flare can develop which takes the form of dermatitis with intense redness, stinging and burning that can spread beyond the initial treatment area. It is more likely to occur when delicate skin sites such as the face and flexures are treated. Should there be a reoccurrence of the condition within days to weeks after successful treatment a withdrawal reaction should be suspected. Reapplication should be with caution and specialist advise is recommended in these cases or other treatment options should be considered.
None Known.
Pregnancy
Since safety of topical corticosteroid use in pregnant women has not been established, drugs of this class should be used during pregnancy only if the potential benefit justifies the potential risk to the foetus. Drugs of this class should not be used extensively in large amounts for prolonged periods of time in pregnant patients.
Breast-feeding
It is not known whether topical administration of corticosteroids could result in sufficient systemic absorption to produce detectable quantities in breast milk. Alclometasone should be administered to nursing mothers only after careful consideration of the benefit/risk relationship.
Not applicable.
Adverse reactions reported rarely with alclometasone dipropionate are itching, burning, erythema, dryness, irritation, and papular rashes.
Other local adverse reactions associated with topical corticosteroids, especially under occlusive dressings, include folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, skin maceration, secondary infection, skin atrophy, striae and miliaria.
Excessive prolonged use may result in local atrophy of the skin, striae and superficial vascular dilation, particularly on the face.
Skin and subcutaneous tissue disorders
Not known (cannot be estimated from available data): Withdrawal reactions - redness of the skin which may extend to areas beyond the initial affected area, burning or stinging sensation, itch, skin peeling, oozing pustules. (see section 4.4)
Reporting of suspected adverse reactions
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store).
Acute overdosage with dermatologic application of corticosteroids is unlikely and would not be expected to lead to a life-threatening situation.
Symptoms: Excessive or prolonged use of topical corticosteroids can suppress pituitary-adrenal function, resulting in secondary adrenal insufficiency, and produce manifestations of hypercorticism, including Cushing's disease.
Treatment: Appropriate symptomatic treatment is indicated. Acute hypercorticoid symptoms are usually reversible. Treat electrolyte imbalance, if necessary. In case of chronic toxicity, slow withdrawal of corticosteroids is advised.
The steroid content is so low as to have little or no effect in the unlikely event of accidental oral ingestion.
Medicines sold in Poland with the same active substance: W Polsce znany jako
⚠ Not the same combination. This medicine contains Alclometasone dipropionate. The products below do not contain exactly the same set of active substances — they are not direct substitutes.
Some of these do not contain exactly the same active substances — check each one. The strength, the form and whether you need a prescription can differ. Always ask a pharmacist before you switch. Polish medicines in the UK →
Ask anything about Alclometasone Dipropionate 0.05% w/w Cream. The assistant answers only from this leaflet — if the leaflet does not cover it, it will say so. It does not give medical advice.
Answers come from the patient leaflet published on the electronic medicines compendium (emc). They are not medical advice. Ask a pharmacist or your GP if you are unsure. For urgent help call NHS 111, or 999 in an emergency.
We use essential cookies to make the site work. We would also like to set optional cookies to understand how the site is used, so we can improve it. We will not set optional cookies unless you accept. See our cookie policy and privacy policy.